AnalystsJohn WilkinJohn Wilkin's Stock Forecasts
AnalystsJohn Wilkin
Sectors:
Industries:
Analyst Ranking
Top 37%
#1841 out of 5064 analysts
Average Return
+44.37%
Win Rate
80%4 out of 5
Risk vs Reward
Poor
Good
John Wilkin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Personalis IncPSNL | +124.47% | $3.80 | $8.53 | 2025-03-17 - 2025-10-15 | Buy |
Adaptive Biotechnologies CorpADPT | +63.42% | $10.47 | $17.11 | 2025-06-18 - 2025-10-15 | Buy |
Exagen IncXGN | +62.84% | $7.32 | $11.92 | 2025-07-23 - 2025-10-15 | Buy |
Veracyte IncVCYT | +9.23% | $31.84 | $34.78 | 2025-03-20 - 2025-10-15 | Buy |
John Wilkin Analyst Color
Get additional color on John Wilkin's coverage of popular stocks
John Wilkin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Exagen IncXGN | 1 | Buy | $12.00 | +0.67% | Initiates Coverage On | 3 months ago |
Adaptive Biotechnologies CorpADPT | 1 | Buy | $15.00 | -12.33% | Initiates Coverage On | 4 months ago |
Veracyte IncVCYT | 1 | Buy | $45.00 | +29.38% | Initiates Coverage On | 7 months ago |
Personalis IncPSNL | 1 | Buy | $8.00 | -6.21% | Initiates Coverage On | 7 months ago |
Myriad Genetics IncMYGN | 1 | Buy | $29.00 | +258.02% | Initiates Coverage On | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.